Skip to content

Efficacy, safety, and outcomes of Foley catheter, misoprostol and their combination for pre-induction cervical ripening in late-term pregnancy at Adeoyo Maternity Hospital- A Randomised Controlled Trial

Efficacy, safety, and outcomes of Foley catheter, misoprostol and their combination for pre-induction cervical ripening in late-term pregnancy at Adeoyo Maternity Hospital- A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202512713453419
Enrollment
60
Registered
2025-12-08
Start date
2025-11-10
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-induction cervical ripening with Foley catheter, Misoprostol and their combination

Interventions

ARM 1 Mechanical method Foley catheter
ARM 2 Pharmacological method Misoprostol
ARM 3 Synchronous Foley catheter with vaginal misoprostol

Sponsors

Ajani Ezekiel Babatunde
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Estimated gestational age of 41weeks to 41weeks +6days Unfavourable cervix (modified Bishop score, mBS of 1.52m Intact foetal membranes A reactive non-stress test Normal amniotic fluid index (AFI)

Exclusion criteria

Exclusion criteria: Medical conditions e.g. pregnancy-induced hypertension, gestational diabetes, asthma, glaucoma Clotting disorders Hypersensitivity to any of the methods Multiple gestations Previous surgeries, e.g. Caesarean section, myomectomy Active genital warts Antepartum Haemorrhage (placenta praevia, abruptio placenta)

Design outcomes

Primary

MeasureTime frame
-Time from placement of cervical ripening agents to time to achieve a favourable BS of =6 within 24 hours of intervention

Secondary

MeasureTime frame
Maternal- Ripening to active phase interval - Ripening to vaginal delivery interval within 24 hours - Oxytocin requirement - Cumulative misoprostol doses - Mode of delivery: Caesarean section, vaginal delivery or operative vaginal delivery - Foley catheter insertion to expulsion time - Method related adverse events: Fever, shivering, anaphylaxis, intracervical bleeding, balloon rupture, purulent vaginal discharge, chorioamnionitis, failed ripening, tachysystole, hypertonus, uterine hyperstimulation, PPH, and uterine rupture. - Participants’ satisfaction Neonatal - Meconium-stained liquor - Apgar score <7 at 1 and 5minutes - SCBU admission - Perinatal death

Countries

Nigeria

Contacts

Public ContactAdeniji Olanrewaju Adediran

Chief Medical Director Adeoyo Maternity Hospital

adenijiolanrewaju2@gmail.com07030165740

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026